Jay Lucidarme

3.5k total citations
71 papers, 2.1k citations indexed

About

Jay Lucidarme is a scholar working on Microbiology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jay Lucidarme has authored 71 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Microbiology, 67 papers in Epidemiology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jay Lucidarme's work include Bacterial Infections and Vaccines (71 papers), Pneumonia and Respiratory Infections (66 papers) and Infective Endocarditis Diagnosis and Management (15 papers). Jay Lucidarme is often cited by papers focused on Bacterial Infections and Vaccines (71 papers), Pneumonia and Respiratory Infections (66 papers) and Infective Endocarditis Diagnosis and Management (15 papers). Jay Lucidarme collaborates with scholars based in United Kingdom, Italy and France. Jay Lucidarme's co-authors include Ray Borrow, Shamez Ladhani, Mary Ramsay, Jamie Findlow, Helen Campbell, Steve Gray, S. A. Clark, Mariagrazia Pizza, Sydel R. Parikh and Stephen J. Gray and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Jay Lucidarme

69 papers receiving 2.0k citations

Peers

Jay Lucidarme
Jamie Findlow United Kingdom
G Bjune Norway
Jenny MacLennan United Kingdom
Tessa M. John United Kingdom
Xilian Bai United Kingdom
Rhonwen Morris United Kingdom
L. Pais United States
Jamie Findlow United Kingdom
Jay Lucidarme
Citations per year, relative to Jay Lucidarme Jay Lucidarme (= 1×) peers Jamie Findlow

Countries citing papers authored by Jay Lucidarme

Since Specialization
Citations

This map shows the geographic impact of Jay Lucidarme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Lucidarme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Lucidarme more than expected).

Fields of papers citing papers by Jay Lucidarme

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Lucidarme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Lucidarme. The network helps show where Jay Lucidarme may publish in the future.

Co-authorship network of co-authors of Jay Lucidarme

This figure shows the co-authorship network connecting the top 25 collaborators of Jay Lucidarme. A scholar is included among the top collaborators of Jay Lucidarme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay Lucidarme. Jay Lucidarme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
4.
Clark, S. A., Helen Campbell, Sonia Ribeiro, et al.. (2025). Clinical and Microbiological Characteristics of Meningococcal Eye Infections: Retrospective National Surveillance in England, 2010–2022. Clinical Infectious Diseases. 82(1). e9–e16.
5.
Mourkas, Evangelos, Megan De Ste Croix, Jay Lucidarme, et al.. (2024). High-throughput phenotype-to-genotype testing of meningococcal carriage and disease isolates detects genetic determinants of disease-relevant phenotypic traits. mBio. 15(12). e0305924–e0305924. 1 indexed citations
6.
Clark, S. A., Helen Campbell, Sonia Ribeiro, et al.. (2023). Epidemiological and strain characteristics of invasive meningococcal disease prior to, during and after COVID-19 pandemic restrictions in England. Journal of Infection. 87(5). 385–391. 18 indexed citations
7.
Ladhani, Shamez, Helen Campbell, Zahin Amin‐Chowdhury, et al.. (2022). Timing of meningococcal vaccination with 4CMenB (Bexsero®) in children with invasive meningococcal group B (MenB) disease in England. Vaccine. 40(10). 1493–1498. 3 indexed citations
8.
Lucidarme, Jay, et al.. (2021). Increase in penicillin-resistant invasive meningococcal serogroup W ST-11 complex isolates in England. Vaccine. 39(19). 2719–2729. 10 indexed citations
9.
Lucidarme, Jay, Helen Campbell, Dominique A. Caugant, et al.. (2020). Geographically widespread invasive meningococcal disease caused by a ciprofloxacin resistant non-groupable strain of the ST-175 clonal complex. Journal of Infection. 81(4). 575–584. 12 indexed citations
10.
Zhu, Bingqing, Jay Lucidarme, Xilian Bai, et al.. (2019). Comparative genomic analyses of Chinese serogroup W ST-11 complex Neisseria meningitidis isolates. Journal of Infection. 80(1). 54–60. 3 indexed citations
11.
Lucidarme, Jay, et al.. (2019). Meningococcal Serogroup A, B, C, W, X, and Y Serum Bactericidal Antibody Assays. Methods in molecular biology. 1969. 169–179. 10 indexed citations
12.
Harrison, Odile B., Jay Lucidarme, Kadidja Gamougam, et al.. (2018). Development of a PCR algorithm to detect and characterize Neisseria meningitidis carriage isolates in the African meningitis belt. PLoS ONE. 13(12). e0206453–e0206453. 13 indexed citations
13.
Daugla, Doumagoum Moto, Odile B. Harrison, James E. Bray, et al.. (2017). Hierarchical genomic analysis of carried and invasive serogroup A Neisseria meningitidis during the 2011 epidemic in Chad. BMC Genomics. 18(1). 398–398. 13 indexed citations
14.
Knol, Mirjam J., Susan Hahné, Jay Lucidarme, et al.. (2017). Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study. The Lancet Public Health. 2(10). e473–e482. 61 indexed citations
15.
Allam, Mushal, Nicole Wolter, Holly B. Bratcher, et al.. (2017). Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa. BMC Microbiology. 17(1). 40–40. 16 indexed citations
16.
Lucidarme, Jay, Dorothea M. C. Hill, Holly B. Bratcher, et al.. (2015). Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage. Journal of Infection. 71(5). 544–552. 163 indexed citations
17.
Hill, Dorothea M. C., Jay Lucidarme, Stephen J. Gray, et al.. (2015). Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study. The Lancet Infectious Diseases. 15(12). 1420–1428. 49 indexed citations
18.
Ladhani, Shamez, Kazim Beebeejaun, Jay Lucidarme, et al.. (2014). Increase in Endemic Neisseria meningitidis Capsular Group W Sequence Type 11 Complex Associated With Severe Invasive Disease in England and Wales. Clinical Infectious Diseases. 60(4). 578–585. 168 indexed citations
19.
Biolchi, Alessia, Fabio Rigat, Jay Lucidarme, et al.. (2013). Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage. Vaccine. 31(43). 4968–4974. 120 indexed citations
20.
Lucidarme, Jay, Lionel Tan, Rachel M. Exley, et al.. (2011). Characterization of Neisseria meningitidis Isolates That Do Not Express the Virulence Factor and Vaccine Antigen Factor H Binding Protein. Clinical and Vaccine Immunology. 18(6). 1002–1014. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026